Germany – Research laboratory services – Rahmenvertrag über In-Vivo-Studien an NB-PDX-Modellen in Mäusen
- Buyer
- Charité - Universitätsmedizin Berlin
- Country
- Germany
- Published
- 2026-09-24
- Deadline
- 2026-10-23
- Type
- cn-standard
- Status
- Open to bid
- Category
- CPV 73111000
Description
Die Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin schreibt einen Rahmenvertrag über die Durchführung von In-Vivo-Studien (Therapie, Charakterisierung oder Bioverteilung/Pharmakokinetikstudien) an patientenabgeleiteten Neuroblastom-Xenograft-Modellen in Mäusen ("NB-PDX-Modellen") nebst Entnahme von PDX-Tumormaterial aus. Es handelt sich hierbei um einen Rahmenvertrag mit nur einem Auftragnehmer. Es bestehen gesonderte Anforderungen nach dem Berliner Ausschreibungs- und Vergabegesetz (BerlAVG), siehe Vergabeunterlagen. Nähere Informationen können den auf der Vergabeplattform der Charité (https://vergabeplattform.charite.de) zur Verfügung gestellten Unterlagen entnommen werden.
The buyer's description as published on TED (Tenders Electronic Daily). The full notice is at the source.
Around this tender
- Closes tomorrow, on 2026-10-23.
- Charité - Universitätsmedizin Berlin has 21 notices on this site, 14 of them open now, the earliest published 2026-09-24. See them all.
- One of 49 open Research & development tenders in Germany on this site; where a value is published, the median is 338.4k USD.
- Work under the same CPV group (731) is open in 18 other countries: Poland (18), United Kingdom (14), Belgium (9), Norway (5), Spain (5) and 13 more.
Counted from the notices this site holds, which reach back about a month - not everything a buyer has ever published.
Get new Research and development services and related consultancy tenders in Germany by email
One free weekly email with the newest matching notices, each with at least a few days left to respond. No account, unsubscribe in one click.
Other open Research & development tenders in Germany
About this record
This notice was published via TED (Tenders Electronic Daily) and indexed automatically. Figures and dates are reproduced as published at source; always confirm against the original before acting on a deadline.